Key facts
- Notable investors include Ming Bioventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mingcheng Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Mingcheng Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mingcheng Biotechnology
Developer of a biotechnology research technology designed to advance experimental development and drive breakthroughs in the biomedical field. The company offers cutting-edge research technologies, integrated experimental capabilities, and innovative biomedical methodologies, enabling pharmaceutical developers, research institutions, and experimental teams to accelerate scientific discovery and enhance translational research outcomes.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Mingcheng Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mingcheng Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mingcheng Biotechnology in its N-PORT filings yet. We sweep new filings monthly.